These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21982915)

  • 1. Comparative study of a new quantitative rapid test with an established ELISA method for faecal calprotectin.
    Dolci A; Panteghini M
    Clin Chim Acta; 2012 Jan; 413(1-2):350-1. PubMed ID: 21982915
    [No Abstract]   [Full Text] [Related]  

  • 2. A prospective comparative study for new rapid bedside fecal calprotectin test with an established ELISA to assess intestinal inflammation.
    Shastri Y; Povse N; Stein J
    Clin Lab; 2009; 55(1-2):53-5. PubMed ID: 19350850
    [No Abstract]   [Full Text] [Related]  

  • 3. Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation.
    Gearry R; Barclay M; Florkowski C; George P; Walmsley T
    N Z Med J; 2005 May; 118(1214):U1444. PubMed ID: 15886739
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of the Quantum Blue® rapid test for faecal calprotectin.
    Wassell J; Wallage M; Brewer E
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):55-8. PubMed ID: 21930735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Faecal calprotectin: comparative study of the Quantum Blue rapid test and an established ELISA method.
    Coorevits L; Baert FJ; Vanpoucke HJ
    Clin Chem Lab Med; 2013 Apr; 51(4):825-31. PubMed ID: 23001318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
    Malícková K; Janatková I; Bortlík M; Komárek V; Lukás M
    Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):147-53. PubMed ID: 19069028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Faecal calprotectin for the diagnosis of inflammatory bowel disease.
    Logan R
    BMJ; 2010 Jul; 341():c3636. PubMed ID: 20634348
    [No Abstract]   [Full Text] [Related]  

  • 8. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease.
    Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R
    Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J; Dolwani S; Metzner M; Losty H; Hawthorne A
    Ann Clin Biochem; 2004 May; 41(Pt 3):230-2. PubMed ID: 15117438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits.
    Whitehead SJ; French J; Brookes MJ; Ford C; Gama R
    Ann Clin Biochem; 2013 Jan; 50(Pt 1):53-61. PubMed ID: 23129721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a new extraction device for measuring faecal calprotectin in inflammatory bowel disease, and comparison to established extraction methods.
    Kristensen V; Lauritzen T; Jelsness-JØrgensen LP; Moum B
    Scand J Clin Lab Invest; 2015 Sep; 75(5):355-61. PubMed ID: 25856663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of fecal calprotectin test in the work-up of IBS patients.
    Delgado-Aros S; Cremonini F
    Gastroenterology; 2003 Apr; 124(4):1164-5. PubMed ID: 12671919
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study.
    Shastri YM; Povse N; Schröder O; Stein J
    Clin Lab; 2008; 54(9-10):389-90. PubMed ID: 19097497
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Schröder O; Naumann M; Shastri Y; Povse N; Stein J
    Aliment Pharmacol Ther; 2007 Oct; 26(7):1035-42. PubMed ID: 17877510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.
    Grad C; David L; Portincasa P; Dumitraşcu DL
    Rom J Intern Med; 2012; 50(1):3-6. PubMed ID: 22788087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Measurement of calprotectin in faeces].
    Jahnsen J; Røseth AG; Aadland E
    Tidsskr Nor Laegeforen; 2009 Apr; 129(8):743-5. PubMed ID: 19373299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Faecal calprotectin in inflammatory bowel diseases: review].
    Kallel L; Fekih M; Boubaker J; Filali A
    Tunis Med; 2011 May; 89(5):425-9. PubMed ID: 21557177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calprotectin and IBD.
    Lemann M; Mary JY
    Gut; 2005 Sep; 54(9):1349-50; author reply 1350. PubMed ID: 16099812
    [No Abstract]   [Full Text] [Related]  

  • 20. Inflammatory biomarkers predict relapse in IBD.
    Hanaway P; Roseth A
    Gut; 2005 Sep; 54(9):1346-7. PubMed ID: 16099806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.